ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Developing medicines
  • New medicines & data
  • Research using animals

Research using animals

Research involving animals is a vital part of biomedical research and medicine development, helping us to understand and improve the prevention and treatment of diseases in animals and humans.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Animal research and testing has played an important part in almost every medical breakthrough of the last century, helping scientists to understand disease processes and ensuring medicines are safe for patients.

In fact, it is a regulatory requirement to test potential new medicines in animals before they can be tested in humans, with most tested in two species prior to human testing.

In the UK, the use of animals in experiments and testing is regulated under the Animals (Scientific Procedures) Act 1986 (ASPA), with implementation regulated by the Home Office in England, Scotland and Wales and by the Department for Health, Social Security and Public Safety in Northern Ireland. In 2013, ASPA was amended to align UK law with the requirements of the updated EU regulations (EU Directive 2010/63/EU).

Under the Animals (Scientific Procedures) Act 1986, the principles of the 3Rs (replacement, reduction and refinement) provide a framework for conducting humane animal research and promote the use of alternative methods to reduce the number of animals used.

In Great Britain, there were 3.4 million procedures on animals in 2019, a fall of 3% compared with 2018.

The pharmaceutical industry is strongly committed to the principles of the 3Rs, and all ABPI members maintain very high standards of animal welfare, complying with the strict UK and EU regulations, often going above and beyond these regulations.

The pharmaceutical industry continues to drive collaborative initiatives based on the 3Rs at a UK, European and international level.

The ABPI fulfils this commitment further by being a signatory of the Concordat of Openness on Animal Research, alongside 121 companies, organisations, charities and associations. This is a UK commitment to help the public understand more about why animals are used in research.

New medicines & data

  • Medicines Manufacturing Industry Partnership
  • Manufacturing and quality
  • Research using animals
  • Clinical trial transparency

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.